The scope of the FDA's GLP regulations for nonclinical research and testing includes:

• A. Includes any study submitted to the FDA that supports applications for research or marketing permits for products regulated by the FDA
• B. Only clinical trial data
• C. Only studies conducted in primates
• D. Only studies conducted in the United States

Answer: (A)

GLP covers nonclinical safety studies that are used to support regulatory decisions by the FDA. The scope includes any nonclinical study that is submitted to the FDA in support of applications for research or marketing permits for FDA-regulated products, meaning the data can come from various species and locations as long as they are part of the regulatory submission. This broader reach is what ensures the reliability and integrity of the safety data the FDA relies on. It’s not limited to clinical trial data (which fall under different guidelines), nor restricted to studies in primates, nor confined to studies conducted in the United States.